|
五灵胶囊(丸)治疗慢性乙型肝炎临床应用专家共识 |
|
|
1989 中华中医药学会肝胆病分会.五灵胶囊(丸)治疗慢性乙型肝炎临床应用专家共识 黄堂珍.五灵丸治疗慢性乙型肝炎疗效观察[J].贵阳中医学院studyofschizandrininWulingCapsulesinmice[J].Lishizhen 学报,1999,21(2):11-12.MedMaterMedRes,2004,15(8):468-470.DOI:10. [16]HONGDL.Observationonshort-termtherapeuticeffectof3969/j.issn.1008-0805.2004.08.003. wulingpillonchronichepatitisB[J].JiangsuMedJ,1997,王胜春,皇甫孟军,赵辉平,等.五灵胶囊中五味子乙素在小鼠 23(4):287.体内药代动力学研究[J].时珍国医国药,2004,15(8):468- 洪定玲.五灵丸治疗慢性乙型病毒性肝炎短期疗效观察[J].江470.DOI:10.3969/j.issn.1008-0805.2004.08.003. 苏医药,1997,23(4):287.[27]FENGZH,ZHOUYX,WANGSC,etal.Anti-HBVeffectof [17]ZHAOM,XIONGSS,BAQJ,etal.ClinicalobservationonWulingcapsuleinvitro[J].JFourthMilitMedUniv,1997,18 treatingchronicviralhepatitiswithWulingpill[J].JHenan(4):72. MedColl,1994,29(4):353-355.冯志华,周永兴,王胜春,等.五灵胶囊体外抗乙肝病毒的作用 赵敏,熊诗松,巴秋菊,等.中药五灵丸治疗慢性病毒性肝炎临[J].第四军医大学学报,1997,18(4):72. 床观察[J].河南医科大学学报,1994,29(4):353-355.[28]WANGSC,HUYW,ZHAOHP.EffectofWulingCapsuleon [18]SHIJJ,MIAOF,LIUFL.ExperienceofChineseandWesternHepaticInjuriesInducedbyCCl、D-GlaNandLPS[J]. 4 medicinecombinedwithanti-HBVTreatment[J].WorldChinPharmJChinPLA,2005,21(6):413-417.DOI:10.3969/j. JDig,1998,6(S7):482.issn.1008-9926.2005.06.005. 史进军,苗范,刘福利.中西药结合抗乙肝病毒治疗的体会[J].王胜春,胡咏武,赵慧平.五灵胶囊对四氯化碳D-氨基半乳糖 华人消化杂志,1998,6(S7):482.与内毒素所致肝损伤影响[J].解放军药学学报,2005,21(6): [19]LIUJQ,CAOLH,LUXJ,etal.Effectofentecavircombined413-417.DOI:10.3969/j.issn.1008-9926.2005.06.005. withwulingcapsulesinthetreatmentofcompensatedhepatitis[29]JIANGYY,WANGSC,JIANGYP,etal.Efficacyofwuling Bcirrhosis[J].ChinaJPracMed,2021,48(8):116-118.capsulesforexperimentalhepaticfibrosisinrats[J].JFourth DOI:10.3760/cma.j.cn115689-20201221-06260.MilitMedUniv,2001,22(3):265-267.DOI:10.3321/j. 刘加群,曹立华,鲁小杰,等.恩替卡韦联合五灵胶囊治疗代偿issn:1000-2790.2001.03.023. 期乙型肝炎肝硬化的效果[J].中国实用医刊,2021,48(8):江艳艳,王胜春,蒋永培,等.五灵胶囊对大鼠实验性肝纤维化 116-118.DOI:10.3760/cma.j.cn115689-20201221-的治疗作用[J].第四军医大学学报,2001,22(3):265-267. 06260.DOI:10.3321/j.issn:1000-2790.2001.03.023. [20]ZHOUXY,LUORQ,WANL,etal.ClinicalefficacyofWuling[30]HUYW,WANGSC,LIUMY,etal.EffectofWulingcapsule CapsulecombinedwithEntecavirforchronichepatitisBpaoncollagenandmatrixmetalloproteinaseinratswithhepaticfi tients[J].JPractMed,2021,37(22):2939-2945.DOI:brosis[J].ChinHepatol,2010,15(4):276-280.DOI:10. 10.3969/j.issn.1006-5725.2021.22.022.3969/j.issn.1008-1704.2010.04.013. 周晓元,罗润齐,万蕾,等.五灵胶囊联合恩替卡韦治疗慢性乙胡咏武,王胜春,刘明义,等.五灵胶囊对肝纤维化大鼠胶原及 型肝炎的临床疗效[J].实用医学杂志,2021,37(22):2939-基质金属蛋白酶的影响[J].肝脏,2010,15(4):276-280. 2945.DOI:10.3969/j.issn.1006-5725.2021.22.022.DOI:10.3969/j.issn.1008-1704.2010.04.013. [21]ZHUY,FUM,GUOHY,etal.Curativeeffectofwulingcap[31]ZHAOHP,WANGSC,HUYW.EffectsofWuLingcapsules sulecombinedwithentecavirintreatmentofpatientswithcomonTGF-/SmadandRas/ERKsignalpathwayproteininliver β pensatoryhepatitisBcirrhosis[J].LingnanJEmergMed,tissueofliverfibrosisrats[J].ChinJGastroenterolHepatol, 2021,26(6):593-595.DOI:10.3969/j.issn.1671-301X.2009,18(5):392-396.DOI:10.3969/j.issn.1006-5709. 2021.06.010.2009.05.005. 朱莹,付明,郭海燕,等.五灵胶囊联合恩替卡韦治疗乙肝肝硬赵辉平,王胜春,胡咏武.五灵胶囊对肝纤维化大鼠肝组织TGF-/ β 化代偿期患者疗效观察[J].岭南急诊医学杂志,2021,26(6):Smad及Ras/ERK信号通路蛋白的影响[J].胃肠病学和肝病学杂 593-595.DOI:10.3969/j.issn.1671-301X.2021.06.010.志,2009,18(5):392-396.DOI:10.3969/j.issn.1006-5709. [22]NationalEssentialMedicineClinicalApplicationGuidelinesand2009.05.005. PrescriptionCompilationCommittee.Nationalguideforclinical[32]StudyGroupofClinicalPharmacology,XijingHospital,Fourth applicationofessentialdrugs(ChinesePatentMedicine)[S].MilitaryMedicalUniversity.Experimentalstudyonacutetoxici Beijing:People’sMedicalPublishingHouse,2018.tyofWulingcapsuleinmice[R].1998. 国家基本药物临床应用指南和处方集编委会.国家基本药物临第四军医大学西京医院临床药理基础组.五灵胶囊对小鼠灌胃 床应用指南(中成药)[S].北京:人民卫生出版社,2018.给药急性毒性试验研究[R].1998. [23]WANGSC,HUYW,WANGJQ,etal.Teststudyofeffective[33]StudyGroupofWulingPillsinXijingHospital,FourthMilitary pharmacodynamiccomponentsinWuLingcapsules[J].JMedicalUniversity.Animalacutetoxicitytestdataandlitera FourthMilitMedUniv,2004,25(17):1587-1591.DOI:10.tures[R].1989. 3321/j.issn:1000-2790.2004.17.014.第四军医大学西京医院五灵丸课题组.动物急性毒性试验资料 王胜春,胡咏武,王俊琴,等.五灵胶囊药效作用的有效成分及文献资料[R].1989. [J].第四军医大学学报,2004,25(17):1587-1591.DOI:[34]StudyGroupofClinicalPharmacology,FourthMilitaryMedical 10.3321/j.issn:1000-2790.2004.17.014.University.Long-termtoxicitytestofWulingcapsuleonrats [24]CHENXL,PENGJ,QIAOY,etal.Effectsofeffectivecompoafterintragastricadministrationfor180days[R].2000. nentofwulingcapsulesontheRas/ERK,TGF-β/Smadsignal第四军医大学西京医院临床药理基础组.五灵胶囊对大鼠灌胃 pathwayregulatedbyexpressionofHSC-T6byTGF-β1-in给药180天长期毒性试验研究[R].2000. duced[J].ChinaPharmacist,2010,13(12):1697-1701.[35]StudyGroupofWulingPillsinXijingHospital,FourthMilitary DOI:10.3969/j.issn.1008-049X.2010.12.003.MedicalUniversity.Animallongtermtoxicitytestdataandliter 陈晓莉,彭洁,乔逸,等.五灵胶囊有效成分对TGF-1诱导atures[R].1992. β HSC-T6表达Ras/ERK、TGF-β/Smad信号通路蛋白的影响第四军医大学西京医院五灵丸课题组.动物长期毒性试验资料 [J].中国药师,2010,13(12):1697-1701.DOI:10.3969/及文献资料[R].1992. j.issn.1008-049X.2010.12.003. [25]WANGSC,ZHAOHP,HUANGFUMJ.Pharmacokineticof引证本文:BranchofHepatobiliaryDiseases,ChineseAssoci saikosaponindinWulingCapsulesinmouse[J].ChinTraditationofChineseMedicine.Expertconsensusforclinicalappli PatentMed,2005,27(7):809-811.DOI:10.3969/j.issn.cationofWulingcapsule(pill)inthetreatmentofchronichep 1001-1528.2005.07.023.atitisB[J].JClinHepatol,2022,38(9):1986-1989. 王胜春,赵辉平,皇甫孟君.五灵胶囊中柴胡皂苷d在小鼠体内中华中医药学会肝胆病分会.五灵胶囊(丸)治疗慢性乙型肝 药代动力学研究[J].中成药,2005,27(7):809-811.DOI:炎临床应用专家共识[J].临床肝胆病杂志,2022,38(9): 10.3969/j.issn.1001-1528.2005.07.023.1986-1989. [26]WANGSC,HUANGFUMJ,ZHAOHP,etal.Pharmacokinetic (本文编辑:邢翔宇) |
|
|
|
|
|
|
|
|
|
|